Search Results 191-200 of 16305 for Proto-oncogene
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
The eMERGE Genome Informed Risk Assessment study at Mayo Clinic offers healthcare professionals genome informed clinical recommendations for 11 diseases and ...
Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.
Learn about symptoms, diagnosis and treatment of these growths that occur in and around the ovaries and fallopian tubes.
Mayo Clinic Comprehensive Cancer Center combines personalized cancer treatment with leading-edge research to provide you with unparalleled cancer care.
In a prospective, multisite study, 15.2% of patients with pancreatic cancer were found to have a genetic predisposition to this deadly disease.
[ALK]/ c-ros oncogene 1 [ROS1]) per National Comprehensive Cancer Network (NCCN) guidelines, participant has also been previously treated with or is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.